Life Technologies Found Liable for Infringing Promega’s DNA Analysis Patents

On February 23, a district court in the Western District of Wisconsin granted a summary judgment motion finding that various Life Technologies products for DNA analysis, including AmpFISTR PCR kits, infringe Promega’s Patent Numbers 6,221,598; 6,479,235; 7,008,771; and Re37,984. The court awarded $52 million in damages to Promega.

Promega & Max Planck v. Life Technologies, Docket No. 10-cv-281-bbc (W.D.W).

Comments

Popular posts from this blog

Protein folding via charge zippers

Lonza: CMC Product Manager

GlaxoSmithKline (GSK): Esprit Physician Leadership Development Programme